DexCom (NASDAQ:DXCM) : The value of composite uptick trades was $23.7 million, whereas, the value of composite downtick trades was $33.65 million. The uptick to downtick ratio stood at 0.7 with a negative money flow of ($9.95) Million during Wednesdays trading session. The block trades money flow was negative ($10.94 million).The uptick to the downtick ratio of 0.22 in block trades signals that the large investors have utilized the rise in the stock to sell.The uptick transaction value stood at $3.05 million. The transaction of the trades on downticks amounted to $14 million, which confirms investors selling on the strength of price. DexCom (NASDAQ:DXCM) gained 96 cents at $79, an increase of 1.23% over the previous days close.
In an insider trading activity, Balo Andrew K, officer (EVP, Clinical, Regulatory) of Dexcom Inc, unloaded 55,000 shares at an average price of $75 on June 20, 2016. The total amount of the transaction was worth $4,125,000, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing. Currently the company Insiders own 2.8% of DexCom shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -7.86% . Institutional Investors own 94.04% of DexCom shares. During last six month period, the net percent change held by insiders has seen a change of -6.43%.
The company shares have dropped -2.17% from its 1 Year high price. On Sep 17, 2015, the shares registered one year high at $103.29 and the one year low was seen on Feb 8, 2016. The 50-Day Moving Average price is $68.78 and the 200 Day Moving Average price is recorded at $68.67. DexCom (NASDAQ:DXCM): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $78.10 and $78.01 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $81.23. The buying momentum continued till the end and the stock did not give up its gains. It closed at $79.00, notching a gain of 1.23% for the day. The total traded volume was 1,261,454 . The stock had closed at $78.04 on the previous day.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.